7: Peter Hofland, Ph.D - The Onco’Zine Brief - Episode 7

7: Peter Hofland, Ph.D - The Onco’Zine Brief - Episode 7

Episode Overview

• Sonalasense pioneers non-invasive sonodynamic therapy for deadly cancers, including high-grade gliomas
• The therapy's potential for transforming cancer treatment is discussed, offering hope to patients and addressing brain tumor management
• The platform technology's adaptability to various forms of cancer and the prospects of personalized and minimally invasive therapies are highlighted
• Emphasis on pioneering clinical studies and the expansion of sonodynamic therapy into other cancer types beyond brain tumors
• Insights into the futuristic and promising aspects of sonodynamic therapy's potential to revolutionize cancer treatment

“We have to prove the concept of sonodynamic therapy and with Dr. Sanai's pioneering study, that was the first clinical study ever done in man with sonodynamic therapy. We plan to continue with our own studies in recurrent glioblastoma in DIPG and eventually in newly diagnosed glioblastoma, and then expand outside the brain into tumors such as pancreatic carcinoma and other cancers outside the brain to really prove that this is a platform.”